HAMILTON, Bermuda, Sept. 27 /PRNewswire-FirstCall/ -- Warner Chilcott Limited will host a brief conference call on Wednesday, September 27, 2006 beginning at 8:30 AM (ET) to address the Company’s response to the announcement by Barr Pharmaceuticals, Inc. that it intends to launch a generic version of Ovcon(R) 35. The conference call will be open to all interested parties. The number to call within the United States is (800) 894-5910. Participants outside the United States should call (785) 424-1052. The conference call access code is 86524. A replay of the conference call will be available from September 27, 2006 through October 11, 2006 and can be accessed by dialing (888) 215-1533 from within the United States or (402) 220-4939 from outside the United States.
The Company
Warner Chilcott is a leading specialty pharmaceutical company focused on marketing, selling, developing and manufacturing branded prescription products in women’s healthcare and dermatology in the United States.
Warner Chilcott Limited
CONTACT: Paul Herendeen, Chief Financial Officer of Warner Chilcott,+1-973-442-3200, pherendeen@wcrx.com
Web site: http://www.wclabs.com/
